Rahul warns NDA government again…

  Bengaluru: Congress Vi…

Cloudy Saturday morning in Delhi

  New Delhi: It was a cl…

Actively working towards clean p…

  New Delhi:  Finance Mi…

President-elect Ram Nath Kovind …

  New Delhi: Sanjay Koth…

1,180 pilgrims leave for Amarnat…

  Jammu: A fresh batch o…

Ananth Kumar blames Mamata for D…

New Delhi: Parliamentary …

Goa proved lucky for Kovind: Par…

  Panaji: The Goa Assemb…

JioPhone to bring new era of inn…

  New Delhi: With Mukesh…

Reliance Jio launches JioPhone f…

  Mumbai: Industrialist …

Madhya Pradesh legislators queue…

Bhopal: Legislators queue…

«
»
TwitterFacebookPinterestGoogle+

Anticoagulants Market Continued to be driven by Aging Population and Rising Prevalence of Coagulation Disorders: Ken Research

Facebooktwittergoogle_plusredditpinterestlinkedinmail

Anticoagulants are class of drug used for prevention of blood clots. These substances are majorly available in leeches and blood-sucking insects. These drugs have found major application in treatment of thrombotic disorders and as supporting drug during dialysis. The drug is applied on test tubes, transfusion bags, and renal dialysis equipment for proper functioning. Though the drug class results in various side effects; anticoagulants play an important role in treatment of atrial fibrillation, coronary artery disease, deep vein thrombosis, ischemic stroke, myocardial infraction and pulmonary embolism.
Global anticoagulants market is broadly divided by type into six segments including Heparin, Warfarin, Noval Oral Anticoagulants, Vitamin K Antogonists, Direct Thrombosis Inhibitors, and others. The market is also segmented on the basis of route of administration into oral and injections. Various global pharmaceutical giants including Pfizer, Sanofi, GSK, and Baxter provide anticoagulants in their portfolio for prevention of blood clots.
Aging population and rising prevalence of coagulation disorders are the major factors which are expected to drive the anticoagulants market during future. However, unawareness about the disease especially in emerging and undeveloped economies of Asia, Latin America and Africa results in large number of undiagnosed cases of coagulation disorders, hence restraining the market.

Leave a Reply

Your email address will not be published. Required fields are marked *

CAPTCHA Image

*